Alnylam Pharmaceuticals
ALNY
#660
Rank
HK$301.62 B
Marketcap
HK$2,259
Share price
0.62%
Change (1 day)
-8.09%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company